Fernando Aranda

Has grant

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Contrato postdoctoral Sara Borrell

Open Date: 2016-01-01

Close Date: 2018-12-01

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

FRANCISCO LOZANO

Professor Titular

University of Barcelona

SPAIN

View details

Lourdes Mengual

Associate professor

University of Barcelona

SPAIN

View details

MARIA VELASCO DE ANDRES

SPAIN

View details

Pedro Berraondo

SPAIN

View details

Esther Carreras

Associate Professor - L03

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Celia Gomar

Universidad de Navarra

SPAIN

View details

Alvaro Teijeira

Centro de Investigación Médica Aplicada, Universidad de Navarra

SPAIN

View details

Pablo Engel

Professor

University of Barcelona

SPAIN

View details

Maite Alvarez

SPAIN

View details

WEN SHEN

Joan and Sanford I Weill Medical College of Cornell University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fernando Aranda

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis

Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8<sup>+</sup> T cells eradicates peritoneal metastases in mouse models.

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis.

Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution

CD6 deficiency impairs early immune response to bacterial sepsis

Novel strategies exploiting interleukin-12 in cancer immunotherapy

Revisiting intracavitary immunotherapy of cancer

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors.

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy.

Firefighters for the Wrong Type of Inflammation in Tumors

Collaborators (10)

FRANCISCO LOZANO

Lourdes Mengual

MARIA VELASCO DE ANDRES

Pedro Berraondo

Esther Carreras

Celia Gomar

Alvaro Teijeira

Pablo Engel

Maite Alvarez

WEN SHEN

Make your next move.